Skip to content
Subscriber Only

Moderna’s Covid Deals Top $18 Billion; Medical Chief Exits

  • Vaccine maker sees up to 125 million doses made in quarter
  • Tal Zaks to leave in September as focus shifts to global sales
Updated on

Moderna Inc. said it has reached $18.4 billion worth of signed agreements for its Covid-19 vaccine in 2021, and Chief Medical Officer Tal Zaks will leave the company in late September.

The shot-maker is seeking a replacement for Zaks with “global and commercial experience” as it scales up manufacturing and shepherds other products to market over the next few years, according to a statement Thursday. Its Covid-19 vaccine sales have the potential to grow even further as the biotech continues to negotiate supply agreements with governments around the world.